462 related articles for article (PubMed ID: 19757485)
1. Targeting of plasmid DNA-lipoplexes to cells with molecules anchored via a metal chelator lipid.
Herringson TP; Patlolla RR; Altin JG
J Gene Med; 2009 Nov; 11(11):1048-63. PubMed ID: 19757485
[TBL] [Abstract][Full Text] [Related]
2. Convenient targeting of stealth siRNA-lipoplexes to cells with chelator lipid-anchored molecules.
Herringson TP; Altin JG
J Control Release; 2009 Nov; 139(3):229-38. PubMed ID: 19595724
[TBL] [Abstract][Full Text] [Related]
3. pDNA-lipoplexes engrafted with flagellin-related peptide induce potent immunity and anti-tumour effects.
Faham A; Herringson T; Parish C; Suhrbier A; Khromykh AA; Altin JG
Vaccine; 2011 Sep; 29(40):6911-9. PubMed ID: 21798298
[TBL] [Abstract][Full Text] [Related]
4. The novel chelator lipid 3(nitrilotriacetic acid)-ditetradecylamine (NTA(3)-DTDA) promotes stable binding of His-tagged proteins to liposomal membranes: potent anti-tumor responses induced by simultaneously targeting antigen, cytokine and costimulatory signals to T cells.
van Broekhoven CL; Altin JG
Biochim Biophys Acta; 2005 Oct; 1716(2):104-16. PubMed ID: 16225839
[TBL] [Abstract][Full Text] [Related]
5. How does the spacer length of cationic gemini lipids influence the lipoplex formation with plasmid DNA? Physicochemical and biochemical characterizations and their relevance in gene therapy.
Muñoz-Úbeda M; Misra SK; Barrán-Berdón AL; Datta S; Aicart-Ramos C; Castro-Hartmann P; Kondaiah P; Junquera E; Bhattacharya S; Aicart E
Biomacromolecules; 2012 Dec; 13(12):3926-37. PubMed ID: 23130552
[TBL] [Abstract][Full Text] [Related]
6. Increasing the antitumor efficacy of doxorubicin-loaded liposomes with peptides anchored via a chelator lipid.
Herringson TP; Altin JG
J Drug Target; 2011 Sep; 19(8):681-9. PubMed ID: 21142652
[TBL] [Abstract][Full Text] [Related]
7. S4(13)-PV cell penetrating peptide and cationic liposomes act synergistically to mediate intracellular delivery of plasmid DNA.
Trabulo S; Mano M; Faneca H; Cardoso AL; Duarte S; Henriques A; Paiva A; Gomes P; Simões S; de Lima MC
J Gene Med; 2008 Nov; 10(11):1210-22. PubMed ID: 18729238
[TBL] [Abstract][Full Text] [Related]
8. Serum-resistant lipoplexes in the presence of asialofetuin.
Tros de Ilarduya C
Methods Mol Biol; 2010; 605():425-34. PubMed ID: 20072898
[TBL] [Abstract][Full Text] [Related]
9. Tunable pDNA/DODAB:MO lipoplexes: the effect of incubation temperature on pDNA/DODAB:MO lipoplexes structure and transfection efficiency.
Silva JP; Oliveira AC; Lúcio M; Gomes AC; Coutinho PJ; Oliveira ME
Colloids Surf B Biointerfaces; 2014 Sep; 121():371-9. PubMed ID: 25023903
[TBL] [Abstract][Full Text] [Related]
10. Effective tumor targeting and enhanced anti-tumor effect of liposomes engrafted with peptides specific for tumor lymphatics and vasculature.
Herringson TP; Altin JG
Int J Pharm; 2011 Jun; 411(1-2):206-14. PubMed ID: 21443937
[TBL] [Abstract][Full Text] [Related]
11. High mobility group box 1 protein enhances polyethylenimine mediated gene delivery in vitro.
Shen Y; Peng H; Deng J; Wen Y; Luo X; Pan S; Wu C; Feng M
Int J Pharm; 2009 Jun; 375(1-2):140-7. PubMed ID: 19442462
[TBL] [Abstract][Full Text] [Related]
12. Why is less cationic lipid required to prepare lipoplexes from plasmid DNA than linear DNA in gene therapy?
Muñoz-Úbeda M; Misra SK; Barrán-Berdón AL; Aicart-Ramos C; Sierra MB; Biswas J; Kondaiah P; Junquera E; Bhattacharya S; Aicart E
J Am Chem Soc; 2011 Nov; 133(45):18014-7. PubMed ID: 21985329
[TBL] [Abstract][Full Text] [Related]
13. Enhanced hepatocyte-selective in vivo gene expression by stabilized galactosylated liposome/plasmid DNA complex using sodium chloride for complex formation.
Fumoto S; Kawakami S; Ito Y; Shigeta K; Yamashita F; Hashida M
Mol Ther; 2004 Oct; 10(4):719-29. PubMed ID: 15451456
[TBL] [Abstract][Full Text] [Related]
14. [Feasibility of chitosan as gene therapy vehicle].
Wan YY; Zhang X; He YJ; Jiang WQ
Ai Zheng; 2005 Nov; 24(11):1408-11. PubMed ID: 16552973
[TBL] [Abstract][Full Text] [Related]
15. Formulations which increase the size of lipoplexes prevent serum-associated inhibition of transfection.
Turek J; Dubertret C; Jaslin G; Antonakis K; Scherman D; Pitard B
J Gene Med; 2000; 2(1):32-40. PubMed ID: 10765503
[TBL] [Abstract][Full Text] [Related]
16. The gene-silencing effect of siRNA in cationic lipoplexes is enhanced by incorporating pDNA in the complex.
Tagami T; Barichello JM; Kikuchi H; Ishida T; Kiwada H
Int J Pharm; 2007 Mar; 333(1-2):62-9. PubMed ID: 17097247
[TBL] [Abstract][Full Text] [Related]
17. Nuclear localisation sequence templated nonviral gene delivery vectors: investigation of intracellular trafficking events of LMD and LD vector systems.
Keller M; Harbottle RP; Perouzel E; Colin M; Shah I; Rahim A; Vaysse L; Bergau A; Moritz S; Brahimi-Horn C; Coutelle C; Miller AD
Chembiochem; 2003 Apr; 4(4):286-98. PubMed ID: 12672108
[TBL] [Abstract][Full Text] [Related]
18. Heparin-conjugated polyethylenimine for gene delivery.
Jeon O; Yang HS; Lee TJ; Kim BS
J Control Release; 2008 Dec; 132(3):236-42. PubMed ID: 18597881
[TBL] [Abstract][Full Text] [Related]
19. Non-covalent association of folate to lipoplexes: a promising strategy to improve gene delivery in the presence of serum.
Duarte S; Faneca H; de Lima MC
J Control Release; 2011 Feb; 149(3):264-72. PubMed ID: 21044650
[TBL] [Abstract][Full Text] [Related]
20. Ca(2+)-mediated anionic lipid-plasmid DNA lipoplexes. Electrochemical, structural, and biochemical studies.
Barrán-Berdón AL; Yélamos B; Malfois M; Aicart E; Junquera E
Langmuir; 2014 Oct; 30(39):11704-13. PubMed ID: 25211646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
